Test Price
2,800 AED✅ Home Collection Available
CDSN Gene Hypotrichosis Type 2 NGS Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection – Available daily from 8 AM to 11 PM.
- Clinical Guidance: Post‑Test Telephonic Consultation for detailed result interpretation.
- Insurance Verification: Direct Billing Support via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The CDSN Gene Hypotrichosis Type 2 NGS Test employs next‑generation sequencing to detect pathogenic variants in the CDSN gene, confirming autosomal recessive hypotrichosis with high precision. This test is vital for differential diagnosis, carrier screening, and personalised family planning guidance.
| Feature | Our Advanced NGS CDSN Test | Closest Alternative (Conventional Single‑Gene Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full CDSN gene coverage | Sanger sequencing – limited to targeted regions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Diagnostic Sensitivity | 99.9% | ~95% |
| Price (AED) | 2,800 | 3,500+ |
| UAE Regulatory Compliance | Full DHA/MOHAP, ISO 9001:2015, PDPL | Often limited |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that genetic testing for hypotrichosis provides critical molecular evidence for accurate diagnosis and recurrence risk counseling. Interpretation must be integrated with a complete clinical evaluation and family history. Patients should receive pre- and post-test genetic counseling to address psychological and familial implications of autosomal recessive inheritance.”
— Lina Osama Zaki Quteineh | DHA Registration ID: 9294403
Advisory: Medication & Clinical Continuity
⚠️ Important: Do not discontinue prescribed medication or alter treatment plans without consulting your healthcare provider. Genetic test results inform clinical decisions but must never replace professional medical judgment.
Safety Protocol – Exclusion Criteria & Emergency Red Flags
- Active infection or open wound at the venipuncture site.
- Severe anemia or bleeding disorder that may compromise sample integrity.
- Inability to provide informed consent – mandatory for all patients under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Pregnancy is not a contraindication but requires documented clinical notation.
- Emergency Red Flags after sample collection: Excessive bleeding, persistent fainting, or signs of an allergic reaction (swelling, rash, breathing difficulty) – seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What exactly does the CDSN Gene Hypotrichosis Type 2 NGS test detect?
This high‑throughput sequencing test identifies pathogenic variants across the entire CDSN gene, providing a definitive molecular diagnosis of autosomal recessive hypotrichosis type 2, essential for accurate genetic counseling and recurrence risk assessment in affected families.
2. How is the sample collected and what preparation is required?
A standard peripheral blood sample is collected by a certified phlebotomist. No special preparation is required, but you should provide a detailed clinical history. A pre-test genetic counseling session to construct a family pedigree is strongly recommended for accurate interpretation.
3. Are my genetic data and personal information kept confidential under UAE law?
Yes. All genetic and health data are processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Data is encrypted, anonymized, and never shared with third parties without your explicit written consent.
UAE Regulatory & Data Privacy Adherence
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – Full encryption, anonymization, and explicit consent requirements.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Secure digital health data handling.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – Patient consent and safety protocols.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
- DHA Facility License Number: 1143.
- 24/7 Support: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | CDSN Gene Hypotrichosis Type 2 Genetic Test – NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Q84.0 |
| LOINC Code | 92039-4 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians